Skip to main content
SMMT logo

SMMT · Summit Therapeutics Inc.

$12.79 +0.24 (+1.91%)
Market Cap
$10.01B
Shares
797.75M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Manmeet Soni $249,127,782
Mahkam Zanganeh $246,047,279
Robert Duggan $172,376
Fiscal 2024
Executive Total
Manmeet Soni $4,772,489
Mahkam Zanganeh $1,161,021
Ankur Dhingra $256,280
Robert Duggan $158,613
Fiscal 2023
Executive Total
Manmeet Soni $23,613,339
Mahkam Zanganeh $20,562,924
Ankur Dhingra $621,251
Robert Duggan
Fiscal 2022
Executive Total
Ankur Dhingra $1,362,850
Mahkam Zanganeh $1,242,049
Robert Duggan
Fiscal 2021
Executive Total
Mahkam Zanganeh $9,639,214
David Powell $1,606,698
Jeffrey Maranian $1,044,147
Robert Duggan
Fiscal 2020
Executive Total
Michael Donaldson $961,418
Ventzislav Stefanov $674,823
Glyn Edwards $621,822
Mahkam Zanganeh $527,312
David Powell $401,124
Robert Duggan
Fiscal 2019
Executive Total
Glyn Edwards $871,908
Robert Duggan
Key facts CIK 1599298 CUSIP 86627T108 13F (30d) 33 filings 33 filers Visit website Investor relations